ACE and COVID-19: These findings are reflected in the current guidelines from the American Heart Association, ACC, Heart Failure Society of America, European Society of Cardiology, and National Institutes of Health (NIH), which recommend the use of ACE inhibitors or ARBs for patients who are already prescribed such agents for cardiovascular disease and do not recommend use for the treatment of COVID-19.